Moderna Stock Falls On Potential FDA Delay For Covid Vaccine In Teens

Moderna Stock Falls On Potential FDA Delay For Covid Vaccine In Teens

Moderna stock dipped Friday on a report the FDA is delaying its review of the company's Covid vaccine in teens.